Remote Gene Therapy Business Development Manager

Danaher Corporation; Paris; Teletrabalho; EUR 110 000 - 140 000; Tempo integral

Vantagens oferecidas por esta oferta de emprego

Remote work eligibility

Health benefits

Paid time off

Resumo da oferta

Cytiva, a Danaher operating company, seeks a Business Development Manager for Gene Therapy to drive commercial growth and technical adoption across advanced therapy workflows. You will cover Belgium, the Netherlands, Luxembourg and France in a remote role, collaborating with Field Application Specialists to train customers and expand Cytiva solutions.

Ideal candidates hold a life sciences degree and have experience in bioprocessing, gene therapies, vaccines, or advanced therapies, with CRM

Qualificações

• Bachelor's degree in Life Sciences or related field.
• Experience in bioprocessing, cell/gene therapy, vaccines, or advanced therapy commercialization.
• CRM experience for opportunity tracking (e.g., SFDC).

Responsabilidades

• Own advanced therapy workflows including viral vectors and nucleic acids.
• Drive order growth by expanding Cytiva technologies with existing customers.
• Test, demonstrate, and deliver technical training at customer sites with Field Application Specialists.
• Support marketing and lead generation activities and events to generate and convert MQLs.
• Manage CRM and funnel execution in SFDC aligned with playbooks.

Conhecimentos

Bioprocessing

Technical sales

Viral vectors

Design-In programs

Lead generation

Formação académica

Bachelor's degree in Life Sciences

Ferramentas

SFDC (Salesforce)

Descrição da oferta de emprego

Cytiva, a Danaher operating company, seeks a Business Development Manager for Gene Therapy to drive commercial growth and technical adoption across advanced therapy workflows. You will cover Belgium, the Netherlands, Luxembourg and France in a remote role, collaborating with Field Application Specialists to train customers and expand Cytiva solutions.

Ideal candidates hold a life sciences degree and have experience in bioprocessing, gene therapies, vaccines, or advanced therapies, with CRM